Skip to main content
Erschienen in: Inflammation 6/2014

01.12.2014

IL-22 Enhances CCL20 Production in IL-1β-Stimulated Human Gingival Fibroblasts

verfasst von: Yoshitaka Hosokawa, Ikuko Hosokawa, Satoru Shindo, Kazumi Ozaki, Takashi Matsuo

Erschienen in: Inflammation | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

CC chemokine ligand 20 (CCL20) is involved in the recruitment of Th17 cells and thus in the exacerbation of periodontal disease, but the effect of simultaneous interleukin (IL)-22 and IL-1β stimulation on CCL20 production in human gingival fibroblasts (HGFs) is uncertain. In this study, we investigated the mechanisms of IL-1β- and/or IL-22-induced CCL20 production in HGFs. A single stimulation of IL-22 could not induce CCL20 production. On the other hand, IL-22 could increase CCL20 production from IL-1β-stimulated HGFs in a dose-dependent manner. C-Jun N terminal kinase (JNK) and inhibitor of nuclear factor κB (IκB)-α phosphorylation were increased in IL-1β- and IL-22-stimulated HGFs. An inhibitor of nuclear factor (NF)-κB decreased IL-1β- and IL-22-induced CCL20 production, though an inhibitor of JNK did not modulate CCL20 production. These data suggest that IL-1β in cooperation with IL-22 could increase Th17 cell accumulation in periodontally diseased tissues to enhance CCL20 production in HGFs.
Literatur
1.
Zurück zum Zitat Taubman, M.A., and T. Kawai. 2001. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Critical Reviews in Oral Biology and Medicine 12: 125–135.PubMedCrossRef Taubman, M.A., and T. Kawai. 2001. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Critical Reviews in Oral Biology and Medicine 12: 125–135.PubMedCrossRef
2.
Zurück zum Zitat Afar, B., D. Engel, and E.A. Clark. 1992. Activated lymphocyte subsets in adult periodontitis. Journal of Periodontal Research 27: 126–133.PubMedCrossRef Afar, B., D. Engel, and E.A. Clark. 1992. Activated lymphocyte subsets in adult periodontitis. Journal of Periodontal Research 27: 126–133.PubMedCrossRef
3.
Zurück zum Zitat Lappin, D.F., O. Koulouri, M. Radvar, P. Hodge, and D.F. Kinane. 1999. Relative proportions of mononuclear cell types in periodontal lesions analyzed by immunohistochemistry. Journal of Clinical Periodontology 26: 183–189.PubMedCrossRef Lappin, D.F., O. Koulouri, M. Radvar, P. Hodge, and D.F. Kinane. 1999. Relative proportions of mononuclear cell types in periodontal lesions analyzed by immunohistochemistry. Journal of Clinical Periodontology 26: 183–189.PubMedCrossRef
4.
Zurück zum Zitat Kawai, T., T. Matsuyama, Y. Hosokawa, S. Makihira, M. Seki, N.Y. Karimbux, R.B. Goncalves, P. Valverde, S. Dibart, Y.P. Li, L.A. Miranda, C.W. Ernst, Y. Izumi, and M.A. Taubman. 2006. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. American Journal of Pathology 169: 987–998.PubMedCentralPubMedCrossRef Kawai, T., T. Matsuyama, Y. Hosokawa, S. Makihira, M. Seki, N.Y. Karimbux, R.B. Goncalves, P. Valverde, S. Dibart, Y.P. Li, L.A. Miranda, C.W. Ernst, Y. Izumi, and M.A. Taubman. 2006. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. American Journal of Pathology 169: 987–998.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Han, X., T. Kawai, J.W. Eastcott, and M.A. Taubman. 2006. Bacterial-responsive B lymphocytes induce periodontal bone resorption. Journal of Immunology 176: 625–631.CrossRef Han, X., T. Kawai, J.W. Eastcott, and M.A. Taubman. 2006. Bacterial-responsive B lymphocytes induce periodontal bone resorption. Journal of Immunology 176: 625–631.CrossRef
6.
Zurück zum Zitat Gaffen, S.L., and G. Hajishengallis. 2008. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. Journal of Dental Research 87: 817–828.PubMedCentralPubMedCrossRef Gaffen, S.L., and G. Hajishengallis. 2008. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. Journal of Dental Research 87: 817–828.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Hirota, K., H. Yoshitomi, M. Hashimoto, S. Maeda, S. Teradaira, N. Sugimoto, T. Yamaguchi, T. Nomura, H. Ito, T. Nakamura, N. Sakaguchi, and S. Sakaguchi. 2007. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. Journal of Experimental Medicine 204: 2803–2812.PubMedCentralPubMedCrossRef Hirota, K., H. Yoshitomi, M. Hashimoto, S. Maeda, S. Teradaira, N. Sugimoto, T. Yamaguchi, T. Nomura, H. Ito, T. Nakamura, N. Sakaguchi, and S. Sakaguchi. 2007. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. Journal of Experimental Medicine 204: 2803–2812.PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Hosokawa, Y., I. Hosokawa, K. Ozaki, H. Nakae, and T. Matsuo. 2005. Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin. Clinical and Experimental Immunology 142: 285–291.PubMedCentralPubMedCrossRef Hosokawa, Y., I. Hosokawa, K. Ozaki, H. Nakae, and T. Matsuo. 2005. Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin. Clinical and Experimental Immunology 142: 285–291.PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Hosokawa, Y., I. Hosokawa, K. Ozaki, H. Nakae, and T. Matsuo. 2012. Interleukin (IL)-17A synergistically enhances CC chemokine ligand 20 production in IL-1β-stimulated human gingival fibroblasts. Human Immunology 73: 26–30.PubMedCrossRef Hosokawa, Y., I. Hosokawa, K. Ozaki, H. Nakae, and T. Matsuo. 2012. Interleukin (IL)-17A synergistically enhances CC chemokine ligand 20 production in IL-1β-stimulated human gingival fibroblasts. Human Immunology 73: 26–30.PubMedCrossRef
10.
Zurück zum Zitat Liang, S.C., X.Y. Tan, D.P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L.A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. Journal of Experimental Medicine 203: 2271–2279.PubMedCentralPubMedCrossRef Liang, S.C., X.Y. Tan, D.P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L.A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. Journal of Experimental Medicine 203: 2271–2279.PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Kotenko, S.V., L.S. Izotova, O.V. Mirochnitchenko, E. Esterova, H. Dickensheets, R.P. Donnelly, and S. Pestka. 2001. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. Journal of Biological Chemistry 276: 2725–2732.PubMedCrossRef Kotenko, S.V., L.S. Izotova, O.V. Mirochnitchenko, E. Esterova, H. Dickensheets, R.P. Donnelly, and S. Pestka. 2001. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. Journal of Biological Chemistry 276: 2725–2732.PubMedCrossRef
12.
Zurück zum Zitat Marijnissen, R.J., M.I. Koenders, R.L. Smeets, M.H. Stappers, C. Nickerson-Nutter, L.A. Joosten, A.M. Boots, and W.B. van den Berg. 2011. Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation. Arthritis and Rheumatism 63: 2939–2948.PubMedCrossRef Marijnissen, R.J., M.I. Koenders, R.L. Smeets, M.H. Stappers, C. Nickerson-Nutter, L.A. Joosten, A.M. Boots, and W.B. van den Berg. 2011. Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation. Arthritis and Rheumatism 63: 2939–2948.PubMedCrossRef
13.
Zurück zum Zitat Hughes, T., B. Becknell, A.G. Freud, S. McClory, E. Briercheck, J. Yu, C. Mao, C. Giovenzana, G. Nuovo, L. Wei, X. Zhang, M.A. Gavrilin, M.D. Wewers, and M.A. Caligiuri. 2010. Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity 32: 803–814.PubMedCentralPubMedCrossRef Hughes, T., B. Becknell, A.G. Freud, S. McClory, E. Briercheck, J. Yu, C. Mao, C. Giovenzana, G. Nuovo, L. Wei, X. Zhang, M.A. Gavrilin, M.D. Wewers, and M.A. Caligiuri. 2010. Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity 32: 803–814.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Ikeuchi, H., T. Kuroiwa, N. Hiramatsu, Y. Kaneko, K. Hiromura, K. Ueki, and Y. Nojima. 2005. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis and Rheumatism 52: 1037–1046.PubMedCrossRef Ikeuchi, H., T. Kuroiwa, N. Hiramatsu, Y. Kaneko, K. Hiromura, K. Ueki, and Y. Nojima. 2005. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis and Rheumatism 52: 1037–1046.PubMedCrossRef
15.
Zurück zum Zitat Lejeune, D., L. Dumoutier, S. Constantinescu, W. Kruijer, J.J. Schuringa, and J.C. Renauld. 2002. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. Journal of Biological Chemistry 277: 33676–33682.PubMedCrossRef Lejeune, D., L. Dumoutier, S. Constantinescu, W. Kruijer, J.J. Schuringa, and J.C. Renauld. 2002. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. Journal of Biological Chemistry 277: 33676–33682.PubMedCrossRef
16.
Zurück zum Zitat Andoh, A., Z. Zhang, O. Inatomi, S. Fujino, Y. Deguchi, Y. Araki, T. Tsujikawa, K. Kitoh, S. Kim-Mitsuyama, A. Takayanagi, N. Shimizu, and Y. Fujiyama. 2005. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129: 969–984.PubMedCrossRef Andoh, A., Z. Zhang, O. Inatomi, S. Fujino, Y. Deguchi, Y. Araki, T. Tsujikawa, K. Kitoh, S. Kim-Mitsuyama, A. Takayanagi, N. Shimizu, and Y. Fujiyama. 2005. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129: 969–984.PubMedCrossRef
Metadaten
Titel
IL-22 Enhances CCL20 Production in IL-1β-Stimulated Human Gingival Fibroblasts
verfasst von
Yoshitaka Hosokawa
Ikuko Hosokawa
Satoru Shindo
Kazumi Ozaki
Takashi Matsuo
Publikationsdatum
01.12.2014
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 6/2014
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-9939-5

Weitere Artikel der Ausgabe 6/2014

Inflammation 6/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.